Dear Colleagues,
following the annual tradition of assembling outstanding experts at Freiburg University to let them share their insights on advances in multiple myeloma (MM), we are very happy to welcome you all to the 16th MM Meeting 2025. Over the last years, remarkable advances in the field have steadily improved the outcome of patients suffering from plasma cell dyscrasias. Myeloma physicians, both in the clinic and outpatient office, face challenges as the options available add up to a whole variety of valuable treatment strategies.
"16th MM Meeting 2025: Qestions + answers in immune therapies in MM" is the title of our 2025 workshop meeting, which is a live Hybrid meeting again.
We have invited worldwide eminent authorities from the US, Austria and Germany, who will - with UKF experts plus commentary guests - share their data with us in straightforward discussion rounds.
Therewith, we will cover new treatment modalities in MM, will solve, where the future in MM evolves to, what are current, worldwide trials from the US and Europe and pending solutions needed for this disease.
Cordially looking forward to seeing you during this meeting in November 2025.
Prof. Dr. Monika Engelhardt Sektionsleitung Klinische Forschung + MM-Programm UKF Klinik für Innere Medizin I | Prof. Dr. Ralph Wäsch Sektionsleitung Medizinische Zelltherapie +Zellforschung (SMZZ) + MM-Programm UKF Klinik für Innere Medizin I | Prof. Dr. Justus Duyster Ärztlicher Direktor Klinik für Innere Medizin I Klinischer Direktor des Tumorzentrums Freiburg - CCCF |
Programm
The 2024 Program Flyer as a PDF-file
Speakers and chairs
Registration
The Myeloma Workshop 2025 is an hybrid live event. Participation is possible on site and online and is free of charge.
Online registration for on-site attendance will open soon.
And if you have any questions, do not hesitate to contact us.
Sponsors
Platinum sponsors
Gold sponsors
Silber sponsors
We thank all our sponsors for greatly supporting this meeting.
Amgen GmbH - 10.000€ for a 4sqm booth and advertising purposes
AbbVie Deutschland GmbH&Co KG - 3.000 € for a 4sqm booth and advertising purposes
Bristol-Myers Squibb GmbH & Co. KGaA - 10.000€ for a 4sqm booth and advertising purposes
GlaxoSmithKline GmbH & Co. KG - 1.500€ for a 4 sqm booth
Janssen-Cilag GmbH -10.000€ for a 4sqm booth and advertising purposes
Menarini Stemline Deutschland GmbH - 4.500€ for a 4sqm booth and advertising purposes
Oncopeptides GmbH - 1.500€ for a 4sqm booth and advertising purposes
Pfizer Pharma GmbH - 4.500€ for a 4sqm booth and advertising purposes
Sanofi-Aventis Deutschland GmbH - 4.500€ for a 4sqm booth and advertising purposes
Takeda Pharma Vertrieb GmbH & Co.KG - 1.500€ for a 4 sqm booth
Contact
Organizing committee
Medical Center University of Freiburg
Department of Medicine I - Specialties: Hematology, Oncology and Stem Cell Transplantation
Hugstetter Straße 55 I 79106 Freiburg
Prof. Dr. Monika Engelhardt
Mandy-Deborah Möller
Prof. Dr. Ralph Wäsch
Sina Wenger
Stephanie Lavielle
AG Engelhardt
Sektion Klinische Forschung & ECTU MED1
CCCF
Prof. Justus Duyster, Prof. Christoph Peters and CCCF Team
Internet:
www.uniklinik-freiburg.de /medizin1
www.uniklinik.freiburg.de/cccf
Congress Organizer
Medical Center University of Freiburg
Communication Department | Event Management
Elke Bührer
Breisacher Str. 153
79110 Freiburg
+49 761 270-19210
veranstaltung@uniklinik-freiburg.de